Surrogates of the Left Ventricular Thrombus Resolution: A Retrospective Data Review

OBJECTIVE
The left ventricular thrombus is one of the serious complications of ischemic cardio- myopathy. In this study, we aimed to search for the independent factors to predict the resolu- tion of left ventricular thrombus.

METHODS
This retrospective study included all patients with coronary artery disease, aged above 18 years old, and with the thrombus at the apical location of the left ventricle. Demographic, clinical, and echocardiographic characteristics of the patients were recorded. Major adverse cardiovascular events developed within the follow-up period were recorded. The time in the therapeutic range of each patient was calculated. The presence of left ventricular thrombus beyond 180 days despite warfarin usage was classified as persistent left ventricular thrombus.

RESULTS
The study included 174 subjects (169 males and 5 females). The mean age of the study population was 54.5 ± 11.0 years. The number of patients in whom the left ven- tricular thrombus resolved with treatment in less than 180 days was 56 (32.2%). Median anticoagulation time in the study population was 252 [150-480] days and the meantime in the therapeutic range of the patients was 54 ± 19%. The time in therapeutic range value of the groups was similar (P =.593). It was found that concomitant clopidogrel use (P =.003) and left ventricular thrombus area (P <.001) were the independent predictors of left ventricular thrombus resolution within less than 180 days in the logistic regression analysis.

CONCLUSION
Concomitant use of clopidogrel was found to be associated with left ventricular thrombus resolution but left ventricular thrombus size was related to left ventricular thrombus persistency. Although standard 3-6 months of anticoagulation is advised for left ventricular thrombus, considering the presence of these predictors in such patients may guide the physi- cians to individualize the treatment.